Digital stress-management interventions show no benefit over usual care in breast cancer patients at 18 months

A randomized controlled trial published 4 November 2026 reports no measurable advantage for the interventions at final follow-up.

Stands on 1 first-party reading of PubMed and ClinicalTrials.gov, not reporting.

Breast cancer patients find no relief from digital stress tools AI illustrationhow this picture was made

A randomized controlled trial examining digital stress interventions for breast cancer patients was published November 4, 2026. The work appears in Breast Cancer Research and Treatment, indexed on PubMed ^[1]. 430 patients were randomized to receive one of two digital stress management programs, or usual care. 76% of enrolled participants, 327 people, completed the 18 month follow up survey. At 18 months, all three groups showed stable trends over time. The authors reported no significant difference in perceived stress between either intervention group and the control arm. Perceived stress was specified as the trial's primary outcome prior to launch.

Proof1 source · 1 publisher · signed

What this stands on

"Effects of digital stress-management interventions in breast cancer patients 18 months after intervention access." published in Breast cancer research and treatment as a randomized controlled trial (PubMed 42980875, doi 10.1007/s10549-026-08117-x). Sample: 327 as stated in the abstract. Duration: 18 months. Primary outcome: The a priori defined aims of the current study were to examine; 1) whether extended (18 months) access to the digital stress-management interventions CBI and MBI were associ · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact recordUnited Statesofficial source

Read directly from PubMed and ClinicalTrials.gov, the public registries of published studies and registered trials, not from anyone's report of it.